Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro
- PMID: 18778785
- DOI: 10.1016/j.cellbi.2008.08.014
Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro
Abstract
Mesenchymal stem cells (MSCs) are pluripotent adult stem cells. It has been shown that MSCs secrete neurotrophic factors involving nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Also, these neurotrophic factors can upregulate tyrosine hydroxylase (TH) gene expression in PC12 cells and neural stem cells. Here, we investigated the effect of co-culturing rat E13.5 ventral mesencephalic cells (VMCs) with MSCs from rat bone marrow on TH expression and dopamine (DA) content. The study consisted of 3 groups: MSC, VMC and a combined MSC+VMC group. All groups were cultured in serum-free neuro-basal medium for 3 days. Thereafter, each group was analyzed by RT-PCR, western blotting, and HPLC. The co-culture group showed a higher expression at TH and DA than the VMC group. However, TH and DA were not present in the MSC group. These observations suggest that MSCs could be an alternative source for treating neurodegenerative diseases such as Parkinson's disease (PD).
Similar articles
-
Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.Cell Transplant. 2009;18(7):801-14. doi: 10.3727/096368909X470801. Epub 2009 Sep 28. Cell Transplant. 2009. PMID: 19796495
-
Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.Biol Blood Marrow Transplant. 2010 Nov;16(11):1530-40. doi: 10.1016/j.bbmt.2010.06.006. Epub 2010 Jun 10. Biol Blood Marrow Transplant. 2010. PMID: 20542127
-
Intrastriatal grafts of mesenchymal stem cells in adult intact rats can elevate tyrosine hydroxylase expression and dopamine levels.Cell Biol Int. 2009 Dec 16;34(1):135-40. doi: 10.1042/CBI20090012. Cell Biol Int. 2009. PMID: 19947946
-
Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.Brain Res Brain Res Rev. 2004 Dec;47(1-3):126-44. doi: 10.1016/j.brainresrev.2004.05.002. Brain Res Brain Res Rev. 2004. PMID: 15572168 Review.
-
Neuronal cell replacement in Parkinson's disease.J Intern Med. 2009 Oct;266(4):358-71. doi: 10.1111/j.1365-2796.2009.02155.x. J Intern Med. 2009. PMID: 19765180 Review.
Cited by
-
Combination of butylphthalide with umbilical mesenchymal stem cells for the treatment of delayed encephalopathy after carbon monoxide poisoning.Medicine (Baltimore). 2016 Dec;95(49):e5412. doi: 10.1097/MD.0000000000005412. Medicine (Baltimore). 2016. PMID: 27930518 Free PMC article. Clinical Trial.
-
Mesenchymal Stem Cells: Generalities and Clinical Significance in Feline and Canine Medicine.Animals (Basel). 2023 Jun 7;13(12):1903. doi: 10.3390/ani13121903. Animals (Basel). 2023. PMID: 37370414 Free PMC article. Review.
-
Stem Cell Transplantation and Physical Exercise in Parkinson's Disease, a Literature Review of Human and Animal Studies.Stem Cell Rev Rep. 2018 Apr;14(2):166-176. doi: 10.1007/s12015-017-9798-1. Stem Cell Rev Rep. 2018. PMID: 29270820 Review.
-
Mesenchymal stem cells for the treatment of neurodegenerative disease.Regen Med. 2010 Nov;5(6):933-46. doi: 10.2217/rme.10.72. Regen Med. 2010. PMID: 21082892 Free PMC article. Review.
-
Unraveling the Bone-Brain Axis: A New Frontier in Parkinson's Disease Research.Int J Mol Sci. 2024 Nov 29;25(23):12842. doi: 10.3390/ijms252312842. Int J Mol Sci. 2024. PMID: 39684552 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources